These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1112531)

  • 1. [Diagnostic usefulness of a chemical method of determination of rifampicin in urine].
    Janiszewski M; Szewczyk I
    Gruzlica; 1975 Feb; 43(2):157-62. PubMed ID: 1112531
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiological assay versus spectrophotometry for determination of rifampicin in urine.
    George J; Bhatia VN; Balakrishnan S
    Indian J Lepr; 1988 Jan; 60(1):47-52. PubMed ID: 3060546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin desacetylation in the human organism.
    Maggi N; Furesz S; Pallanza R; Pelizza G
    Arzneimittelforschung; 1969 Apr; 19(4):651-4. PubMed ID: 5819167
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].
    Winsel K; Eule H; Werner E; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):253-6. PubMed ID: 4011658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methods of determination of rifampicin in the urine].
    Ioffe RA
    Antibiotiki; 1973 Sep; 18(9):799-802. PubMed ID: 4761951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Method for determination of rifampicin in urine].
    Georgescu P; Muşeţeanu R; Zaharescu C
    Ftiziologia; 1971; 20(1):93-6. PubMed ID: 5162269
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda.
    Meissner PE; Musoke P; Okwera A; Bunn JE; Coulter JB
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):903-8. PubMed ID: 12365577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemical determination of rifampicin in the urine].
    Wareska W
    Gruzlica; 1972 May; 40(5):419-24. PubMed ID: 5030597
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary excretion of rifampicin and its metabolites as an index of rifampicin blood levels.
    Wardell WM; McQueen EG
    N Z Med J; 1970 Dec; 72(463):393-6. PubMed ID: 5278257
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion of rifampin with urine during treatment of patients with tuberculosis].
    Ioffe RA
    Probl Tuberk; 1973; 51(12):43-6. PubMed ID: 4782103
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption.
    Ellard GA; Fourie PB
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S301-8; discussion S317-21. PubMed ID: 10593709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results with rifampicin therapy of chronic tuberculosis].
    Böszörményi M
    Orv Hetil; 1973 Sep; 114(37):2215-21. PubMed ID: 4741358
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rejection reaction and use of rifampicin in the treatment of tuberculosis in kidney transplantation].
    Farge D; Charpentier B; Simonneau G; Benoit G; Fries D
    Nephrologie; 1985; 6(2):53-7. PubMed ID: 3895010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New anti-tubercular agents--rifampicin and ethambutol].
    El'nik VI
    Klin Med (Mosk); 1971 May; 49(5):8-11. PubMed ID: 4946528
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin levels in blood, urine and kidney tissue in patients with renal tuberculosis].
    Mochalova TP; Kanevskaia SS; Danilova NK
    Antibiotiki; 1973 Feb; 18(2):178-80. PubMed ID: 4776397
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods of clinical evaluation of rifampicin-activity.
    Trendelenburg F
    Acta Tuberc Pneumol Belg; 1969; 60(3):432-6. PubMed ID: 4906099
    [No Abstract]   [Full Text] [Related]  

  • 18. [Local therapeutic trials of various forms of extrapulmonary tuberculosis using rifampicin suspension].
    Basacopol A; Burzoni FJ; Munteanu E
    Maroc Med; 1974 May; 54(579):314-6. PubMed ID: 4444315
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance.
    Liu Y; Cui J; Wang R; Wang X; Drlica K; Zhao X
    J Antimicrob Chemother; 2005 Dec; 56(6):1172-5. PubMed ID: 16207765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of experimental tuberculosis in guinea pigs by continuous and intermittent regimen with special reference to ethambutol and rifampicin].
    Westfal I; Wiza J; Rudnicka M; Szymaczek-Meyer L
    Gruzlica; 1973 Jan; 41(1):1-8. PubMed ID: 4686876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.